3 results
Primary objective:The primary objective is the difference between the gammaCore®-R and the sham treatment groups in mean reduction in number of episodic migraine days during the last four weeks in the twelve-week randomized period compared with the…
Primary objective:* To compare the rates of complete recovery (alive, free of dialysis and return of serum creatinine to <150% of reference baseline; equivalent to acute kidney disease (AKD) category 0) at Day 14 between the Reltecimod-…
Primary objective:• To assess the clinical safety and effectiveness of Pulse Rate (PR) and Respiration Rate (RR) measuredwith the VSC-MEDlib within the intended use compared to the gold-standard reference devices.Exploratory objective:• To assess…